Zobrazeno 1 - 8
of 8
pro vyhledávání: '"cell-free fetal DNA screening"'
Autor:
Forum T. Shah, Kathryn Steinhaus French, Kathryn E. Osann, Maureen Bocian, Marilyn C. Jones, Lauren Korty
Publikováno v:
Journal of Clinical Medicine, Vol 3, Iss 3, Pp 849-864 (2014)
Until recently, maternal serum analyte levels paired with sonographic fetal nuchal translucency measurement was the most accurate prenatal screen available for Trisomies 18 and 21, (91% and 94% detection and false positive rates of 0.31% and 4.5% res
Externí odkaz:
https://doaj.org/article/9d6823874cf748be9127bbc5136d66c8
Autor:
Wendy S. Meschino, H. Melanie Bedford, Shamim Rashid, Tianhua Huang, Clare Gibbons, Ellen Mak-Tam, Megan K. Priston
Publikováno v:
BMC Pregnancy and Childbirth
Background Prenatal screening for chromosome aneuploidies have constantly been evolving, especially with the introduction of cell-free fetal DNA (cfDNA) screening in the most recent years. This study compares the performance, costs and timing of test
Publikováno v:
Journal of Patient Experience, Vol 5 (2018)
Journal of Patient Experience
Journal of Patient Experience
Purpose: The clinical introduction of innovative prenatal genetic technologies challenges patients and providers to find new ways of fostering informed decision-making in a setting characterized by complexity and uncertainty. As prenatal genetic tech
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kathryn Osann, Kathryn Steinhaus French, Forum T. Shah, Maureen Bocian, Marilyn C. Jones, Lauren Korty
Publikováno v:
Journal of Clinical Medicine; Volume 3; Issue 3; Pages: 849-864
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 3, Iss 3, Pp 849-864 (2014)
Shah, FT; French, KS; Osann, KE; Bocian, M; Jones, MC; & Korty, L. (2014). Impact of Cell-Free Fetal DNA Screening on Patients' Choice of Invasive Procedures after a Positive California Prenatal Screen Result.. Journal of clinical medicine, 3(3), 849-864. doi: 10.3390/jcm3030849. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/3qf0j721
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 3, Iss 3, Pp 849-864 (2014)
Shah, FT; French, KS; Osann, KE; Bocian, M; Jones, MC; & Korty, L. (2014). Impact of Cell-Free Fetal DNA Screening on Patients' Choice of Invasive Procedures after a Positive California Prenatal Screen Result.. Journal of clinical medicine, 3(3), 849-864. doi: 10.3390/jcm3030849. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/3qf0j721
Until recently, maternal serum analyte levels paired with sonographic fetal nuchal translucency measurement was the most accurate prenatal screen available for Trisomies 18 and 21, (91% and 94% detection and false positive rates of 0.31% and 4.5% res
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Agatisa PK; Department of Bioethics, Cleveland Clinic, Cleveland, OH, USA.; Obstetrics, Gynecology and Women's Health Institute, Cleveland, OH, USA., Mercer MB; Office of Patient Experience, Cleveland Clinic Center for Personalized Genetic Healthcare, Cleveland, OH, USA., Mitchum A; Department of Bioethics, Cleveland Clinic, Cleveland, OH, USA., Coleridge MB; Genomic Medicine Institute, Obstetrics, Gynecology and Women's Health Institute, Cleveland, OH, USA., Farrell RM; Department of Bioethics, Cleveland Clinic, Cleveland, OH, USA.; Obstetrics, Gynecology and Women's Health Institute, Cleveland, OH, USA.; Genomic Medicine Institute, Obstetrics, Gynecology and Women's Health Institute, Cleveland, OH, USA.
Publikováno v:
Journal of patient experience [J Patient Exp] 2018 Mar; Vol. 5 (1), pp. 26-33. Date of Electronic Publication: 2017 Aug 30.
Autor:
Shah FT; Cancer Genetics Department, Saint Joseph Hospital, Orange, CA 92868, USA. forum.shah@stjoe.org., French KS; Department of Pediatrics Irvine, University of California, Orange, CA 92868, USA. kasteinh@uci.edu., Osann KE; Department of Pediatrics Irvine, University of California, Orange, CA 92868, USA. kosann@uci.edu., Bocian M; Department of Pediatrics Irvine, University of California, Orange, CA 92868, USA. mebocian@uci.edu., Jones MC; San Diego and Rady Children's Hospital, University of California, San Diego, CA 92037, USA. mjones@rchsd.org., Korty L; San Diego, Fetal Care & Genetics San Diego, University of California, CA 92037, USA. ladennis@ucsd.edu.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2014 Jul 24; Vol. 3 (3), pp. 849-64. Date of Electronic Publication: 2014 Jul 24.